Drugs / Quadrivalent Inactivated Influenza Vaccine (2015-2016 NH formulation), No Preservative
Quadrivalent Inactivated Influenza Vaccine (2015-2016 NH formulation), No Preservative
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02451358 | Jul 2015 → Jan 2017 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Quadrivalent Inactivated Influenza Vaccine (2015-2016 NH formulation), No Preservative | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02451358 ↗ |
| Modality | Vaccine | “Quadrivalent Inactivated Influenza Vaccine (2015-2016 NH formulation), No Preservative” NCT02451358 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT02451358 ↗ |